INTRODUCTION AND OBJECTIVES:
We performed a prospective, randomized trial to assess the safety and efficacy of Tisseelâ, Tachosilâ in tubeless percutaneous nephrolithotomy.
METHODS: A total of 75 patients undergoing tubeless percutaneous nephrolithotomy(PCNL) were randomized to receive Tisseelâ, Tachosilâ and control at the end of the procedure. The three groups were comparable in age, sex, height, weight, body mass index, stone size and in metabolic and anatomic features. (Table 1 ) After stone clearance, at the end of the procedure, the nephrostomy tract was closed with a deep #1-0 silk stitch in group 1 patients. Tisseel sealant was loaded and introduced into nephrostomy tract in group 2 patients. In group 3 patients, Tachosil was dipped in contrast medium, rolled like a cigarette and inserted through the nephrostomy tract. The primary end of this study was to evaluate the efficacy of sealants in PCNL. And, the secondary end was compliance of sealants by pain and hospital stay.
RESULTS: There were no differences in the hemoglobin decrease and blood transfusion requirement among the groups during the operation. (Table 2 ) Serial changes in hemoglobin were comparable among the groups during the hospital stay. (Table 3) There was no significant difference in the extent of postoperative perirenal hematoma formation. (p¼0.694) (Table 4) The average visual analog scale pain score on postoperative 1 day were 1.92AE2.47, 1.72AE1.67 and 1.48AE1.73 respectively in each group. (p¼0.378) The hospital stay were 2.28AE0.93, 2.00AE0.96, and 2.04AE0.99 (p¼0.579) in each group. No long-term sequelae were observed in the median follow up period of 24 months in any patient.
CONCLUSIONS: This study indicates that the hemostatic agents in standard tubeless PCNL were not expected to be effective or mandatory. Additional wide, prospective, randomized studies are required to get more fine clinical evidence for the hemostatic agent usage in tubeless PCNL. 
There is no consensus for the term "staghorn calculi", "partial" or "complete", are designations that do not imply any volume judgment. "Staghorn morphometry", is defined as the stone volumetric burden distribution in the collecting system. Objective. Determine "stone morphometry" by preoperative computed tomography (CT).
METHODS: Retrospective-analytical study. 46 patients, 2012-2016, CT at all. Using OsiriX Software, measurement of: Total stone volume (TSV: volume calculated with the reconstruction of the entire image of the stone), entry calix stone volume (ECSV: component of stone in entry calix), favorable calix stone volume (FCSV: component of stone in favorable calix).
RESULTS: It was observe: TSV: 2753 AE 1423 mm3 and 56867 AE 26781 mm3 (p¼<0,001), ECSV: 580 AE 474 mm3 and 17586 AE 13150 mm3 (p¼<0,001), FCSV: 589 AE 569 mm3 and 17900 AE 13717 mm3 (p¼<0,001), in cases with single and those with ! 2 tracts, respectively. TSV >5000 mm3, has 8 and 60 times greater risk for !2 stages and/or tracts, necessaries for stone free rates (CI 95: 2,05-33,16 and 9,01-40,16).
CONCLUSIONS: Stone morphometry, provides the volumetric stone distribution to be treated, and significantly influences to determine the number of tracts and/or stages necessary to achieve a stone free rate in patients with staghorn calculi who underwent percutaneous nephrolithotomy. INTRODUCTION AND OBJECTIVES: Xanthogranulomatous pyelonephritis (XGP) presents an imaging challenge, as the true diagnosis is usually confirmed histologically after nephrectomy. Patients with radiographically diagnosed XGP but with other circumstances that make nephrectomy an undesirable choice can include those with a solitary kidney, poor overall renal function, or the rare case of bilateral disease. Herein we describe our experience managing these types of patients with percutaneous nephrolithotomy (PCNL).
METHODS: We reviewed the charts of all patients diagnosed with radiographic or pathologic XGP (n¼32) at a single institution from 2009 to 2015. Patient demographics, stone characteristics, and laboratory data including renal function and microbiology were recorded. Outcomes of patients treated with PCNL including surgical complications and post-operative renal function were analyzed. RESULTS: We identified 11 patients (34.4%) who were diagnosed with XGP and managed with PCNL, including 2 patients with bilateral findings (total 13 renal units). Mean age was 39.1 AE 12.6 years, 91% were female, mean body mass index was 27.7 AE 8.0 kg/m 2 , and 55% were diabetic. Median follow up was 38.5 months (IQR 12.9-64.1). A pre-operative nephrostomy tube was placed in 82% of patients and all patients had pre-operative urinary tract infections (UTI), although there was only 45% concordance between pre-operative urine and stone cultures. The mean operative time was 4.1 hours. Table 1 lists post-operative outcomes. The majority of patients (91%) had residual stones, although residual stone growth or new stone formation was rare (8%). Recurrent UTIs were seen in the majority of patients (55%). One kidney (8%) in a patient with bilateral findings was removed due to poor function. Four patients (36%) had post-operative complications: 2 Clavien grade II for additional antibiotics, and 2 Clavien grade IV for intensive care unit admissions due to infection.
CONCLUSIONS: For select patients with radiographically diagnosed XGP, PCNL is a feasible alternative to nephrectomy to preserve ipsilateral renal function, although post-operative infectious complications are common. A larger series of patients with longer-term follow-up will further elucidate the outcomes for this selective management strategy.
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MP68-14 SUPINE MINI PCNL e ARE WE LOOKING AT A RECOURSE TO STANDARD PCNL? -A SINGLE CENTER EXPERIENCE
Arunkumar Balakrishnan*, Chennai, India; Kulthe Ramesh Seetharam Bhat, Bangalore, India; Priyank Shah R, Gaurav Gyvi, Chennai, India INTRODUCTION AND OBJECTIVES: A standard Percutaneous Nephrolithotomy is the standard of care for renal calculus especially those more than 2 cm, which involves the patient in prone position with percutaneous access. In addition to this technique various techniques of using miniaturised scopes and instruments have been described in both prone and supine position. We present our series of mini PCNL in supine postion. A observational study was done to evaluate the efficacy, safety and outcomes of supine mini PCNL(smPCNL) in our patients METHODS: 200 patients underwent smPCNL over a period of 3 years including both retrsospective and prospective cohorts were analysed. Data collection included stone size & location, anaesthesia & operative time, use of stent/ureteric catheter, length of hospital stay, stone clearance & complications. Cases were performed using mini PCNL set, in Galdakao-modified Supine Valdivia / modified supine position using fluoroscopy. Success was defined as patients free of stones or with residual stone fragments <5mm.
RESULTS: The mean stone size was 2.7 cm. There were 36 cases with stone located in a single calyx, while 4 case with stones in multiple calyces . Pelvic stones were 50 in number, while pelvi-calyceal/ pelvi-uretric stones were 61 in number. 28 upper uretric stones with 17 bilateral renal unit stones were present; while there were 4 each of upper calyceal diverticulum stone and upper ureter plus calyceal stone. 93% of the cases required a single puncture while frequency of lower calyceal and middle calyceal puncture was 53% and 42 % respectively. Complete stone clearance was achieved in 190 cases (95%) with 10 cases having residual fragments which were treated with ESWL. 30 cases had simultaneous PCNL & URS for stone clearance. 75% cases were totally tubeless. Mean hospital stay was 2.15 days & overall
